Letter: Does a Screening Trial for Spinal Cord Stimulation in Patients With Chronic Pain of Neuropathic Origin Have Clinical Utility (TRIAL-STIM)? 36-Month Results from a Randomized Controlled Trial.
Peng-Bo Zhou, Hong-Tao Sun
Author Information
- Peng-Bo Zhou: The First School of Clinical Medical, Lanzhou University, Lanzhou, Gansu, People's Republic of China. ORCID
- Hong-Tao Sun: The First School of Clinical Medical, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
No abstract text available.
- Eldabe S, Nevitt S, Griffiths S, et al. Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility (TRIAL-STIM)? 36-Month results from a randomized controlled trial. Neurosurgery. 2023;92(1):75-82.
- Eldabe S, Gulve A, Thomson S, et al. Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness? (TRIAL-STIM Study): study protocol for a randomised controlled trial [published correction appears in Trials. 2019;20(1):610]. Trials. 2018;19(1):633.
- Eldabe S, Duarte RV, Gulve A, et al. Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness (TRIAL-STIM)? A randomised controlled trial. Pain. 2020;161(12):2820-2829.
